Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
about
Catalytic antibodies to HIV: physiological role and potential clinical utilityBeyond new chemical entities: advancing drug development based on functional versatility of antibodiesCovalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.Beneficial catalytic immunity to abeta peptide.Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.Physiological IgM class catalytic antibodies selective for transthyretin amyloid.Back to the future: covalent epitope-based HIV vaccine development.IVIg treatment reduces catalytic antibody titers of renal transplanted patientsSpecific amyloid β clearance by a catalytic antibody construct.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.Constant domain-regulated antibody catalysis.CD4 binding determinant mimicry for HIV vaccine design.Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccineToward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Catalytic antibodies and their applications in biotechnology: state of the art.A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis.Antibody-Mediated Catalysis in Infection and Immunity.A covalent HIV vaccine: is there hope for the future?Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection.Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog.Autoantibody-catalyzed hydrolysis of amyloid beta peptide.
P2860
Q24655912-F920E7FD-FC3A-4FCF-8276-5DBF41F0A04BQ30386064-D0EA4F0F-8BB1-43D7-B4D1-85B259595242Q30481770-1C0446F4-CCA0-4699-9FCB-BCA0109ED7A8Q33549900-5E9CAB63-700D-47C9-9443-A3769E22C371Q33573668-F856488A-EE5D-4818-9709-99F74E0248C3Q33676625-4D9987AD-1F45-4F83-B60F-A9FAC7EE742EQ34597300-66EDDD52-7497-4D81-90EA-AB7CC8C68C13Q34962680-E5A97EEF-BA9A-4308-8F61-1EDC98318514Q35451085-28295834-4083-461F-B766-C79078313EE3Q35880109-E3CE802D-D6F8-4798-AA2F-873F9842C0F9Q36069818-7BE8391B-F3AF-40FE-B05A-355BE40031ABQ36332826-FD255EB1-912D-4DEB-B2C4-6B97D5C832C3Q36469664-D3BA4B86-44A8-40B3-808D-DDDED2F71A12Q37000547-733C2CDB-E2EF-464E-AD52-1464A9D2AF49Q37127735-36826FE8-2108-4D1B-958E-070D68EF094AQ37431843-32C060EF-3B62-4042-A738-C8379568A403Q37944291-CBD4491D-15AB-48DC-BC88-BE2C29385414Q38197955-A1F41932-0496-48E0-9410-1126B0CD663AQ38290090-3C411857-CE31-4A8D-8CD2-4C3D47B720A8Q38743675-F83C4409-DE7B-4F78-AD2A-90FC157F1FD8Q39412526-A2DF35E3-A957-4530-B2F2-BFE68780315DQ39733091-1D936CA0-5D4F-4416-8881-163FB43C3BA0Q40909337-8C70ED4F-9C35-46E2-9BA1-96012BF229BCQ44693889-0A7E19F2-0CDE-4FB3-896A-3A8F30667676Q44745703-7C802D8A-1A49-4495-8C2F-A51E53193AD8Q46845401-5AEBCED6-FE88-46ED-BA0C-84E2950D2768
P2860
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
@en
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
@nl
type
label
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
@en
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
@nl
prefLabel
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
@en
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
@nl
P2093
P2860
P356
P1476
Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
@en
P2093
Carl Hanson
Gita Bhatia
Hiroaki Taguchi
Sangeeta Karle
Stephanie Planque
Sudhir Paul
Yasuhiro Nishiyama
Yong-Xin Zhou
P2860
P304
20429-20435
P356
10.1074/JBC.M300870200
P407
P577
2003-03-28T00:00:00Z